Piascledine Capsule 300m 60S EXP 2/2026 It has been proven clinical

It has been proven clinical experiments that it features in rather high precise and repeatability

New triple core design: New additional non-woven SAP fortified absorbent layer with the highest quality Super Absorbent Polymers resulting in vast improvements in urine absorption capacity to meet requirements for heavier and severe incontinence conditions

Gross weight: 15kgs

adhesives can cause a variety of problems

Piascledine Capsule 300m 60S EXP 2/2026 It has been proven clinicalPIASCLEDINE capsule is indicated for the symptomatic slow acting treatment of hip and knee osteoarthritis. Method of administration: Oral use Capsule is to be swallowed as a whole, without chewing, with a glass of water, generally in the middle of a meal. PIASCLEDINE is not to be used in children and adolescents below the age of 18. In adults, no special warning and or precaution for use were evidenced from clinical studies and or post marketing